{"id":53597,"date":"2023-09-20T09:48:06","date_gmt":"2023-09-20T09:48:06","guid":{"rendered":"https:\/\/medsname.com\/votrient\/"},"modified":"2026-04-30T10:25:11","modified_gmt":"2026-04-30T10:25:11","slug":"votrient","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/votrient\/","title":{"rendered":"Votrient"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Gyors v\u00e1lasz \u2014 Mi a Votrient?<\/h3>\n<p style=\"margin:0;\"><strong>Votrient<\/strong> egy or\u00e1lis tabletta a Novarist\u00f3l, amely <strong>pazopanib 400 mg-ot tartalmaz<\/strong> \u2014 egy multitrget tirozin-kin\u00e1z g\u00e1tl\u00f3 (VEGFR-1\/2\/3, PDGFR-\u03b1\/-\u03b2, KIT) <strong>halad\u00f3 vesesejtes karcin\u00f3ma (RCC)<\/strong> \u00e9s <strong>halad\u00f3 l\u00e1gyr\u00e9sz-sarcoma<\/strong> (kor\u00e1bbi kemoter\u00e1pia ut\u00e1n). Szabv\u00e1nyos d\u00f3zis: <strong>800 mg naponta egyszer, \u00fcres gyomorral<\/strong> (1 \u00f3r\u00e1val \u00e9tel el\u0151tt vagy 2 \u00f3r\u00e1val \u00e9tel ut\u00e1n). <strong>Fekete doboz\u00fa hepatotoxicit\u00e1s figyelmeztet\u00e9s<\/strong> \u2014 s\u00falyos, n\u00e9ha hal\u00e1los m\u00e1jk\u00e1rosod\u00e1s. K\u00f6telez\u0151 heti m\u00e1jfunkci\u00f3s tesztek az els\u0151 9 h\u00e9tben, majd havi rendszeress\u00e9ggel. Egy\u00e9b fontos kock\u00e1zatok: magas v\u00e9rnyom\u00e1s (~40%), hasmen\u00e9s, f\u00e1radts\u00e1g, hajsz\u00edn v\u00e1ltoz\u00e1s (depigment\u00e1ci\u00f3), feh\u00e9rje a vizeletben, QT-intervallum meghosszabbod\u00e1s, art\u00e9ri\u00e1s thromboticus esem\u00e9nyek, GI perfor\u00e1ci\u00f3, sebgy\u00f3gyul\u00e1si zavar.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u26a0 Szakorvosi fel\u00fcgyelet sz\u00fcks\u00e9ges.<\/strong> A r\u00e1kk\u00e9sz\u00edtm\u00e9nyeket csak kezel\u0151 onkol\u00f3gus \u00edrhatja fel meger\u0151s\u00edtett diagn\u00f3zis, kiindul\u00e1si st\u00e1diummeghat\u00e1roz\u00e1s \u00e9s meghat\u00e1rozott kezel\u00e9si terv mellett. Soha ne kezdjen el, ne szak\u00edtson meg, ne m\u00f3dos\u00edtson adagot, \u00e9s ne haszn\u00e1ljon r\u00e1kk\u00e9sz\u00edtm\u00e9nyt onkol\u00f3giai ell\u00e1t\u00e1si terven k\u00edv\u00fcl. A legt\u00f6bb r\u00e1kk\u00e9sz\u00edtm\u00e9ny rendszeres v\u00e9rvizsg\u00e1lati monitoroz\u00e1st ig\u00e9nyel (teljes v\u00e9rk\u00e9p, m\u00e1jfunkci\u00f3, vesefunkci\u00f3), abszol\u00fat kontraindik\u00e1lt terhess\u00e9g alatt, \u00e9s jelent\u0151s gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sokkal rendelkezik.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Titkos\u00edtott fizet\u00e9s<\/strong> \u00b7 <strong>\ud83d\udcb3 Hiteles\u00edtett feldolgoz\u00f3<\/strong> \u00b7 <strong>\ud83d\ude9a Vil\u00e1gszerte sz\u00e1ll\u00edtunk<\/strong> \u00b7 <strong>\u2b50 4,9\/5 1400+ \u00fcgyf\u00e9lt\u0151l<\/strong>\n<\/div>\n<h2 class=\"wp-block-heading\">Mi az Votrient?<\/h2>\n<p>A Votrient a Novartis sz\u00e1jon \u00e1t szedhet\u0151 tablett\u00e1ja, amely <strong>pazopanib 400 mg-ot tartalmaz<\/strong>. Pazopanibot tartalmaz. A pazopanib egy multitrget tirozin-kin\u00e1z g\u00e1tl\u00f3, amely a VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-\u03b1, PDGFR-\u03b2, FGFR-1 \u00e9s KIT ellen hat. A vascularis \u00e9s n\u00f6veked\u00e9si faktor jel\u00e1tvitel g\u00e1tl\u00e1s\u00e1val g\u00e1tolja a tumor angiogenezist \u00e9s n\u00f6veked\u00e9s\u00e9t vascularis tumorokban.<\/p>\n<h2 class=\"wp-block-heading\">Felhaszn\u00e1l\u00e1s \u00e9s indik\u00e1ci\u00f3k<\/h2>\n<ul>\n<li><strong>Halad\u00f3 vesesejtes karcin\u00f3ma (RCC)<\/strong> \u2014 els\u0151 vonal\u00fa \u00e9s citokinter\u00e1pia ut\u00e1n<\/li>\n<li><strong>Halad\u00f3 l\u00e1gyr\u00e9sz-sarcoma (STS)<\/strong> \u2014 kor\u00e1bbi kemoter\u00e1pia ut\u00e1n (PALETTE vizsg\u00e1lat)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Adagol\u00e1s \u00e9s szed\u00e9s m\u00f3dja<\/h2>\n<p>Standard adag: <strong>800 mg naponta egyszer (2 \u00d7 400 mg tabletta) \u00fcres gyomorral<\/strong> \u2014 1 \u00f3r\u00e1val \u00e9tkez\u00e9s el\u0151tt vagy 2 \u00f3r\u00e1val \u00e9tkez\u00e9s ut\u00e1n. Az \u00e9tel ~2-szeres\u00e9re n\u00f6veli a pazopanib felsz\u00edv\u00f3d\u00e1s\u00e1t, ami n\u00f6veli a toxicit\u00e1s kock\u00e1zat\u00e1t.<\/p>\n<ol>\n<li><strong>\u00dcres gyomor \u2014 k\u00f6telez\u0151.<\/strong> \u00c1ll\u00edtson be rutint: szedje 1 \u00f3r\u00e1val reggeli el\u0151tt, VAGY 2 \u00f3r\u00e1val vacsora ut\u00e1n, lefekv\u00e9s el\u0151tt.<\/li>\n<li>Ny\u00e9lje le a tablett\u00e1kat eg\u00e9szben \u2014 ne z\u00fazza \u00f6ssze, oldja fel vagy v\u00e1gja kett\u00e9 (jelent\u0151s felsz\u00edv\u00f3d\u00e1si v\u00e1ltoz\u00e1s l\u00e9phet fel).<\/li>\n<li><strong>K\u00f6telez\u0151 monitoroz\u00e1s:<\/strong> M\u00e1jfunkci\u00f3 vizsg\u00e1lat alap\u00e9rt\u00e9kekk\u00e9nt, majd <strong>hetente az els\u0151 9 h\u00e9tben<\/strong>, majd havonta. V\u00e9rnyom\u00e1sm\u00e9r\u00e9s alap\u00e9rt\u00e9kekk\u00e9nt + minden 1\u20132 h\u00e9tben az els\u0151 6 h\u00e9tben, majd havonta. EKG (QTc) alap\u00e9rt\u00e9kekk\u00e9nt + 4\u20136 h\u00e9t ut\u00e1n. Vizeletvizsg\u00e1lat proteinuri\u00e1ra havonta. Pajzsmirigy-funkci\u00f3 (TFT) 3 havonta.<\/li>\n<li>Adag m\u00f3dos\u00edt\u00e1s: cs\u00f6kkentse 200\u2013400 mg-os l\u00e9p\u00e9sekben \u2265 3-as fokozat\u00fa toxicit\u00e1s, AST\/ALT &gt; 8\u00d7 ULN, s\u00falyos hypertonia, s\u00falyos proteinuria vagy QT-hosszabbod\u00e1s eset\u00e9n.<\/li>\n<li>Sz\u00fcneteltesse a pazopanibot 7\u201314 nappal elekt\u00edv m\u0171t\u00e9t el\u0151tt; folytassa 2\u20134 h\u00e9ttel a sebgy\u00f3gyul\u00e1s befejez\u00e9se ut\u00e1n.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Mell\u00e9khat\u00e1sok<\/h2>\n<p><strong>Gyakori:<\/strong> hasmen\u00e9s, f\u00e1rad\u00e9konys\u00e1g, h\u00e1nyinger, cs\u00f6kkent \u00e9tv\u00e1gy, fogy\u00e1s, hajsz\u00edn v\u00e1ltoz\u00e1s (depigment\u00e1ci\u00f3), magas v\u00e9rnyom\u00e1s, k\u00e9z-l\u00e1b szindr\u00f3ma, \u00edz\u00e9rzet v\u00e1ltoz\u00e1s, ny\u00e1lkah\u00e1rtya-gyullad\u00e1s.<\/p>\n<p><strong>Fontos:<\/strong><\/p>\n<ul>\n<li><strong>M\u00e1jtoxicit\u00e1s (BLACK BOX)<\/strong> \u2014 s\u00falyos, n\u00e9ha hal\u00e1los m\u00e1jk\u00e1rosod\u00e1s. Legt\u00f6bb eset az els\u0151 4\u20139 h\u00e9tben. K\u00f6telez\u0151 m\u00e1jfunkci\u00f3 monitoroz\u00e1s.<\/li>\n<li>Magas v\u00e9rnyom\u00e1s (~40%) \u2014 \u00fajonnan fell\u00e9p\u0151 vagy roml\u00f3; agressz\u00edv kezel\u00e9s sz\u00fcks\u00e9ges<\/li>\n<li>QT-intervallum meghosszabbod\u00e1s \u00e9s torsades<\/li>\n<li>Art\u00e9ri\u00e1s thromboticus esem\u00e9nyek (sz\u00edvinfarktus, stroke, TIA)<\/li>\n<li>V\u00e9rz\u00e9s (orrver\u00e9s, GI, intracranialis)<\/li>\n<li>GI perfor\u00e1ci\u00f3 \u00e9s fistula<\/li>\n<li>Proteinuria, nephroticus szindr\u00f3ma<\/li>\n<li>Hypothyreosis<\/li>\n<li>Reverzibilis posterior leukoencephalopathia szindr\u00f3ma (PRES)<\/li>\n<li>Sebgy\u00f3gyul\u00e1si zavar<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Figyelmeztet\u00e9sek<\/h2>\n<ul>\n<li><strong>Terhess\u00e9g:<\/strong> teratog\u00e9n. Megb\u00edzhat\u00f3 fogamz\u00e1sg\u00e1tl\u00e1s a kezel\u00e9s alatt \u00e9s ut\u00e1na 2 h\u00e9tig.<\/li>\n<li><strong>S\u00falyos m\u00e1jel\u00e9gtelens\u00e9g (Child-Pugh C):<\/strong> Ellenjavallt.<\/li>\n<li><strong>QT-intervallum meghosszabbod\u00e1s, elektrolit egyens\u00falyzavar:<\/strong> korrig\u00e1lja a hypokalaemi\u00e1t\/hypomagnesaemi\u00e1t a kezel\u00e9s megkezd\u00e9se el\u0151tt.<\/li>\n<li><strong>Friss arteri\u00e1lis tromboticus esem\u00e9ny (&lt; 6 h\u00f3nap):<\/strong> Ker\u00fclend\u0151.<\/li>\n<li><strong>Seb\u00e9szeti beavatkoz\u00e1s:<\/strong> tartsd 7\u201314 napig; folytasd 2\u20134 h\u00e9ttel k\u00e9s\u0151bb.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">Kombin\u00e1lhat\u00f3<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Hat\u00e1s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Teend\u0151k<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Er\u0151s CYP3A4 g\u00e1tl\u00f3k (ketokonazol, ritonavir, klaritromicin)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pazopanib szint n\u00f6vel\u00e9se \u2014 toxicit\u00e1s<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cs\u00f6kkentsd a pazopanib adagj\u00e1t 400 mg\/napra, ha elker\u00fclhetetlen.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Er\u0151s CYP3A4-induktorok (rifampicin, fenitoin, karbamazepin, orb\u00e1ncf\u0171)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pazopanib szint cs\u00f6kken\u00e9se \u2014 kezel\u00e9si kudarc<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ker\u00fclje.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">PPI-k (omeprazol, esomeprazol, pantoprazol)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">L\u00e9nyegesen cs\u00f6kkenti a pazopanib felsz\u00edv\u00f3d\u00e1s\u00e1t \u2014 kezel\u00e9si kudarc<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">V\u00e1lts r\u00f6vid hat\u00e1s\u00fa H2-blokkol\u00f3ra; k\u00fcl\u00f6n id\u0151z\u00edt\u00e9s, ha H2-blokkol\u00f3 sz\u00fcks\u00e9ges.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">QT-intervallumot meghosszabb\u00edt\u00f3 szerek (citalopram, ondanszetron, fluorokinolonok, metadon)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Addit\u00edv QT-intervallum meghosszabbod\u00e1s<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ker\u00fcld a kombin\u00e1ci\u00f3t; EKG monitoroz\u00e1s.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Varfarin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">V\u00e9rz\u00e9si kock\u00e1zat; INR ingadoz\u00e1s<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kezdetben heti INR monitoroz\u00e1s.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Grapefruitl\u00e9<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">N\u00f6veli a pazopanib szintj\u00e9t<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ker\u00fclje.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<ul>\n<li>Szobah\u0151m\u00e9rs\u00e9kleten, 15\u201325\u00b0C k\u00f6z\u00f6tt, eredeti blistercsomagol\u00e1sban.<\/li>\n<li>Gyermekek, gyermekv\u00e1llal\u00e1sra k\u00e9pes n\u0151k \u00e9s h\u00e1zi\u00e1llatok el\u0151l el\u00e9rhetetlen helyen.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k a MedsBase-en<\/h2>\n<p>Tov\u00e1bbi onkol\u00f3giai gy\u00f3gyszerek, amelyek e term\u00e9k mellett el\u00e9rhet\u0151k:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/imat\/\"><strong>Imat (imatinib 400 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/imatib\/\"><strong>Imatib (imatinib 100\/400 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/veenat\/\"><strong>Veenat (imatinib 100 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/hu\/anti-cancer-medication\/\">\u00d6sszes r\u00e1kkel szembeni gy\u00f3gyszer b\u00f6ng\u00e9sz\u00e9se \u2192<\/a><\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt kell \u00fcres gyomorral bevenni a Votrientet?<\/h3>\n<p>Az \u00e9tel (k\u00fcl\u00f6n\u00f6sen a magas zs\u00edrtartalm\u00fa) <strong>megdupl\u00e1zhatja a pazopanib felsz\u00edv\u00f3d\u00e1s\u00e1t<\/strong>, ami m\u00e9rgez\u0151 v\u00e9rszinthez vezethet, \u00e9s n\u00f6velheti a hepatotoxicit\u00e1s, hypertonia \u00e9s QT-intervallum meghosszabbod\u00e1s kock\u00e1zat\u00e1t. Vegy\u00e9k be 1 \u00f3r\u00e1val b\u00e1rmely \u00e9tkez\u00e9s el\u0151tt VAGY 2 \u00f3r\u00e1val az utols\u00f3 \u00e9tkez\u00e9s ut\u00e1n. A legt\u00f6bb beteg sz\u00e1m\u00e1ra a legk\u00e9nyelmesebb, ha a pazopanibot lefekv\u00e9s el\u0151tt veszi be (felt\u00e9ve, hogy a vacsora legal\u00e1bb 2 \u00f3r\u00e1val kor\u00e1bban befejez\u0151d\u00f6tt) vagy reggel els\u0151 dolg\u00e1nak.<\/p>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt j\u00e1r a Votrient s\u00falyos hepatotoxicit\u00e1ssal?<\/h3>\n<p>A pazopanib hordoz egy FDA <strong>fekete dobozos figyelmeztet\u00e9st s\u00falyos, n\u00e9ha hal\u00e1los m\u00e1jk\u00e1rosod\u00e1sra vonatkoz\u00f3an<\/strong>. A legt\u00f6bb eset az els\u0151 4\u20139 h\u00e9tben fordul el\u0151. K\u00f6telez\u0151 monitoroz\u00e1s: alapvonalon m\u00e1jfunkci\u00f3s tesztek, majd <strong>hetente az els\u0151 9 h\u00e9tben<\/strong>, majd havonta. Azonnal sz\u00fcntesse meg a pazopanibot, ha az AST\/ALT &gt; 8\u00d7 ULN, vagy ha m\u00e1jk\u00e1rosod\u00e1s t\u00fcnetei jelentkeznek (s\u00e1rgas\u00e1g, s\u00f6t\u00e9t vizelet, s\u00falyos f\u00e1rad\u00e9konys\u00e1g).<\/p>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt v\u00e1ltozik meg a hajsz\u00ednem Votrient szed\u00e9sekor?<\/h3>\n<p>A pazopanib g\u00e1tolja a tiroszin\u00e1z enzimet (ami r\u00e9szt vesz a melanin szint\u00e9zis\u00e9ben), mint mell\u00e9khat\u00e1s. A haj depigment\u00e1ci\u00f3ja \u2014 gyakran dr\u00e1mai, n\u00e9h\u00e1ny h\u00f3napon bel\u00fcl feh\u00e9rr\u00e9 vagy sz\u00fcrk\u00e9v\u00e9 v\u00e1lhat \u2014 visszaford\u00edthat\u00f3 a kezel\u00e9s abbahagy\u00e1s\u00e1val. A betegek kb. 40%-\u00e1t \u00e9rinti. Csak kozmetikai jelent\u0151s\u00e9g\u0171, klinikai hat\u00e1sa nincs.<\/p>\n<h3 class=\"wp-block-heading\">Hogyan kezelik a hypertoni\u00e1t?<\/h3>\n<p>A pazopanib \u00e1ltal kiv\u00e1ltott hypertonia mechanisztikus (a VEGF g\u00e1tl\u00e1s cs\u00f6kkenti a nitrog\u00e9n-monoxid szint\u00e9zist). A betegek kb. 40%-\u00e1t \u00e9rinti, gyakran az els\u0151 6 h\u00e9tben. Aggressz\u00edven kezelend\u0151: els\u0151 vonalban ACE-g\u00e1tl\u00f3 vagy ARB (ramipril, losartan, candesartan), sz\u00fcks\u00e9g eset\u00e9n adjunk hozz\u00e1 CCB-t vagy diuretikumot. Ker\u00fclj\u00fck a pazopanib abbahagy\u00e1s\u00e1t hypertonia miatt, ha a v\u00e9rnyom\u00e1s kontroll\u00e1lhat\u00f3 \u2014 a hypertonia val\u00f3j\u00e1ban korrel\u00e1l a daganatellenes hat\u00e9konys\u00e1ggal.<\/p>\n<h3 class=\"wp-block-heading\">Mi\u00e9rt kell abbahagyni a Votrient szed\u00e9s\u00e9t m\u0171t\u00e9t el\u0151tt?<\/h3>\n<p>A pazopanib rontja a sebgy\u00f3gyul\u00e1st (a VEGF-medi\u00e1lt angiogenezis k\u00f6zponti szerepet j\u00e1tszik a sebgy\u00f3gyul\u00e1sban) \u00e9s n\u00f6veli a v\u00e9rz\u00e9s kock\u00e1zat\u00e1t. Sz\u00fcneteltesse <strong>7\u201314 nappal az elekt\u00edv m\u0171t\u00e9t el\u0151tt<\/strong>. Csak a seb teljes gy\u00f3gyul\u00e1sa ut\u00e1n folytassa, \u00e1ltal\u00e1ban <strong>2\u20134 h\u00e9ttel a m\u0171t\u00e9t ut\u00e1n<\/strong>. Minden seb\u00e9sznek \u00e9s fogorvosnak sz\u00f3ljon a pazopanib szed\u00e9s\u00e9r\u0151l.<\/p>\n<h3 class=\"wp-block-heading\">Szedhetek PPI-t Votrient mellett?<\/h3>\n<p>A PPI-k (omeprazol, pantoprazol, ezomeprazol) n\u00f6velik a gyomorsav pH-j\u00e1t \u00e9s jelent\u0151sen cs\u00f6kkentik a pazopanib felsz\u00edv\u00f3d\u00e1s\u00e1t \u2014 kezel\u00e9si kudarc kock\u00e1zat\u00e1val j\u00e1r. V\u00e1ltson r\u00f6vid hat\u00e1s\u00fa H2-blokkol\u00f3ra (famotidin) \u00e9s v\u00e1lassza el az adagol\u00e1st legal\u00e1bb 2 \u00f3r\u00e1val, VAGY haszn\u00e1ljon antacidot csak t\u00fcneti kezel\u00e9sre, legal\u00e1bb 2 \u00f3r\u00e1val elv\u00e1lasztva a pazopanib adagol\u00e1s\u00e1t\u00f3l.<\/p>\n<h3 class=\"wp-block-heading\">Ihatok alkoholt Votrient szed\u00e9se mellett?<\/h3>\n<p>Korl\u00e1tozza az alkoholfogyaszt\u00e1st \u2014 mind az alkohol, mind a pazopanib hepatotoxikus, \u00e9s a kombin\u00e1ci\u00f3 n\u00f6veli a s\u00falyos m\u00e1jk\u00e1rosod\u00e1s kock\u00e1zat\u00e1t. Alkalmank\u00e9nt kis mennyis\u00e9g m\u00e9g elfogadhat\u00f3 lehet, de a napi vagy nagy mennyis\u00e9g\u0171 iv\u00e1st ker\u00fclni kell.<\/p>\n<h3 class=\"wp-block-heading\">A Votrient gy\u00f3gy\u00edtja a r\u00e1komat?<\/h3>\n<p>A pazopanib \u00e1ltal\u00e1ban nem gy\u00f3gy\u00edt\u00f3 hat\u00e1s\u00fa el\u0151rehaladott vesesejtes r\u00e1kban vagy szark\u00f3m\u00e1ban, de jelent\u0151s betegs\u00e9gkontrollt eredm\u00e9nyez. Vesesejtes r\u00e1kn\u00e1l a pazopanibbal t\u00f6rt\u00e9n\u0151 els\u0151 vonalbeli kezel\u00e9s sor\u00e1n a medi\u00e1n progresszi\u00f3mentes t\u00fal\u00e9l\u00e9s k\u00f6r\u00fclbel\u00fcl 11 h\u00f3nap (COMPARZ vizsg\u00e1lat). Szark\u00f3m\u00e1ban kemoter\u00e1pia ut\u00e1n a PFS-n\u00f6veked\u00e9s szer\u00e9nyebb. A kezel\u00e9s a progresszi\u00f3ig vagy elfogadhatatlan toxicit\u00e1sig tart. Az \u00fajabb immunter\u00e1pi\u00e1s kombin\u00e1ci\u00f3k (pembrolizumab + axitinib, nivolumab + cabozantinib) nagyr\u00e9szt felv\u00e1ltott\u00e1k a pazopanib monoter\u00e1pi\u00e1t els\u0151 vonalbeli vesesejtes r\u00e1kn\u00e1l, ahol el\u00e9rhet\u0151k.<\/p>\n<p><!-- medsbase-why-order --><\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Minden t\u00e9tel egy <strong>WHO-GMP tan\u00fas\u00edtott gy\u00e1rt\u00f3<\/strong>. WHO-GMP <a href=\"\/hu\/medsbase-re-shipment-assurance-policy\/\">\u00dajrak\u00fcld\u00e9si Garancia<\/a>: ha egy csomag nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, ingyenes ut\u00e1nk\u00fcld\u00e9st biztos\u00edtunk, k\u00e9rd\u00e9sek n\u00e9lk\u00fcl.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 r\u00e1kellenes gy\u00f3gyszerek<\/h3>\n<p>Tov\u00e1bbi onkol\u00f3giai gy\u00f3gyszerek, amelyek e term\u00e9k mellett el\u00e9rhet\u0151k:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/imatib\/\">Imatib (imatinib 100\/400 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/veenat\/\">Veenat (imatinib 100\/400 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/imat\/\">Imat (imatinib 100\/400 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/riborea\/\">Riborea (ribociclib 200 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/keytruda\/\">Keytruda (pembrolizumab 100 mg)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 G\u00e1tolja a r\u00e1ksejtek n\u00f6veked\u00e9s\u00e9t<br \/>\n\u2705 Kezeli a fejlett veser\u00e1kot<br \/>\n\u2705 Kezeli a l\u00e1gy sz\u00f6veti szark\u00f3m\u00e1t<br \/>\n\u2705 Lass\u00edtja a daganat progresszi\u00f3j\u00e1t<br \/>\n\u2705 Oralis adagol\u00e1s k\u00e9nyelme<\/p>","protected":false},"featured_media":53598,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[],"class_list":{"0":"post-53597","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/53597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=53597"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/53598"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=53597"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=53597"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=53597"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=53597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}